BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
44 results:

  • 1. GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines.
    Nummela P; Zafar S; Veikkolainen E; Ukkola I; Cinella V; Ayo A; Asghar MY; Välimäki N; Törnquist K; Karhu A; Laakkonen P; Aaltonen LA; Ristimäki A
    Int J Cancer; 2024 Jun; 154(11):1987-1998. PubMed ID: 38319157
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survival Outcome in Early-Onset Metastatic colorectal cancer: A Multicenter-Matched Pair Analysis.
    Doleschal B; Niedersüß-Beke D; Kirchweger P; Petzer A; Thaler J; Rumpold H
    Oncology; 2024; 102(2):107-113. PubMed ID: 37699362
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Prognostic Impact of Preoperative Osteopenia in Patients With colorectal cancer.
    Kato H; Seishima R; Mizuno S; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
    Dis Colon Rectum; 2023 Dec; 66(12):e1225-e1233. PubMed ID: 37699124
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
    Anijs RJS; Chen Q; van der Hulle T; Versteeg HH; Klok FA; Lijfering WM; Cannegieter SC
    Thromb Res; 2023 Sep; 229():90-98. PubMed ID: 37421683
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer.
    Chen Y; Sun J; Dong X; Sun D; Qu Y
    World J Surg Oncol; 2023 Jun; 21(1):174. PubMed ID: 37287039
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.
    Su YT; Chen JW; Chang SC; Jiang JK; Huang SC
    Sci Rep; 2022 Nov; 12(1):20075. PubMed ID: 36418865
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study.
    Kawakami T; Masuishi T; Kawamoto Y; Go H; Kato K; Kumanishi R; Sawada K; Yuki S; Yamamoto K; Komatsu Y; Muro K; Fushiki K; Shirasu H; Yamazaki K
    Cancer Med; 2022 Jun; 11(11):2184-2192. PubMed ID: 35182029
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dietary Constituents: Relationship with Breast cancer Prognostic (MCC-SPAIN Follow-Up).
    Dierssen-Sotos T; Gómez-Acebo I; Gutiérrez-Ruiz N; Aragonés N; Amiano P; Molina de la Torre AJ; Guevara M; Alonso-Molero J; Obon-Santacana M; Fernández-Tardón G; Molina-Barceló A; Alguacil J; Marcos-Gragera R; Rodríguez-Cundín P; Castaño-Vinyals G; Canseco Fernandez R; Castilla J; Molinuevo A; Pérez-Gómez B; Kogevinas M; Pollán M; Llorca J
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33374289
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Logistic regression and machine learning predicted patient mortality from large sets of diagnosis codes comparably.
    Cowling TE; Cromwell DA; Bellot A; Sharples LD; van der Meulen J
    J Clin Epidemiol; 2021 May; 133():43-52. PubMed ID: 33359319
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.
    Wei FZ; Mei SW; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Liu Z; Liu Q
    World J Gastroenterol; 2020 Nov; 26(42):6638-6657. PubMed ID: 33268952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis.
    Lin X; Lin K; Lin C; Wang J; Tang Y
    Int Immunopharmacol; 2020 Nov; 88():106946. PubMed ID: 33182023
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Digestive Surgery Intervention for Gynecological Malignant Tumor].
    Kameyama H; Shimada Y; Abe K; Oyanagi H; Nakano M; Nakano M; Ichikawa H; Hanyu T; Takizawa K; Nagahashi M; Sakata J; Kobayashi T; Nishikawa N; Enomoto T; Wakai T
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2176-2178. PubMed ID: 32156870
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic significance of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays.
    Shiraishi T; Shinto E; Nearchou IP; Tsuda H; Kajiwara Y; Einama T; Caie PD; Kishi Y; Ueno H
    Virchows Arch; 2020 Sep; 477(3):409-420. PubMed ID: 32107600
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis.
    Zheng JC; Zheng K; Zhao S; Wang ZN; Xu HM; Jiang CG
    Z Gastroenterol; 2020 Feb; 58(2):137-145. PubMed ID: 32050284
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of extranodal tumor deposits on prognosis and N stage in gastric cancer.
    Liang Y; Wu L; Liu L; Ding X; Wang X; Liu H; Meng J; Xu R; He D; Liang H
    Surgery; 2019 Sep; 166(3):305-313. PubMed ID: 31221435
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Difference in the clinical characteristic and prognosis of colitis-associated cancer and sporadic neoplasia in ulcerative colitis patients.
    Mutaguchi M; Naganuma M; Sugimoto S; Fukuda T; Nanki K; Mizuno S; Hosoe N; Shimoda M; Ogata H; Iwao Y; Kanai T
    Dig Liver Dis; 2019 Sep; 51(9):1257-1264. PubMed ID: 31151895
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
    Abedini P; Fattahi A; Agah S; Talebi A; Beygi AH; Amini SM; Mirzaei A; Akbari A
    J Cell Physiol; 2019 Dec; 234(12):22028-22033. PubMed ID: 31093977
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An Analysis of Relationship Between RAS Mutations and prognosis of Primary Tumour Resection for Metastatic colorectal cancer Patients.
    Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
    Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells.
    Laengle J; Stift J; Bilecz A; Wolf B; Beer A; Hegedus B; Stremitzer S; Starlinger P; Tamandl D; Pils D; Bergmann M
    Theranostics; 2018; 8(12):3198-3213. PubMed ID: 29930723
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Diagnostic value of magnetic resonance versus computed tomography colonography for colorectal cancer: A PRISMA-compliant systematic review and meta-analysis.
    Sun S; Yang C; Huang Z; Jiang W; Liu Y; Wu H; Zhao J
    Medicine (Baltimore); 2018 Jun; 97(22):e10883. PubMed ID: 29851808
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.